Jacqueline Gide

Jacqueline Gide

Auto-generated profile, based on publicly available information

Jacqueline Gide

CECS/AFM, I-STEM, 91100 Corbeil-Essonnes, France

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 November 2019 in Cells
Verified
Journal Article
Open access
PDF file
LBLaetitia Barrault
Laetitia Barrault
JGJacqueline Gide
Jacqueline Gide
TQTingting Qing
Tingting Qing
LLLea Lesueur
Lea Lesueur
Jorg TostJorg Tost
Jorg Tost
SBSandrine BAGHDOYAN
Sandrine BAGHDOYAN
Substantial variations in differentiation properties have been reported among human pluripotent cell lines (hPSC), which could affect their utility and clinical safety. We characterized the variable osteogenic capacity observed between different human pluripotent stem cell lines. By focusing on the miRNA expression profile, we demonstrated that the osteogenic differentiation propensity of human pluripotent stem cell lines could be associated with the methylation status and the expression of miRNAs from the imprinted DLK1/DIO3 locus. More specifically, quantitative analysis of the expression of six different miRNAs of that locus prospectively identified human embryonic stem cells and human-induced pluripotent stem cells with differential osteogenic differentiation capacities. At the molecular and functional levels, we showed that these miRNAs modulated the expression of the activin receptor type 2B and the downstream signal transduction, which impacted osteogenesis. In conclusion, miRNAs of the imprinted DLK1/DIO3 locus appear to have both a predictive value and a functional impact in determining the osteogenic fate of human pluripotent stem cells.